Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

August 5, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase shares for an amount of up to EUR 125 million to cover certain of its obligations arising from its long-term incentive plans. At the current share price, this represents a total of approximately 4.8 million shares.

Philips to repurchase shares for up to EUR 125 million to cover long-term incentive plans

Philips' (PHG) second-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses.

Philips (PHG) Q2 Earnings Rise, Revenues Fall Year Over Year

We recap the Q2 earnings report from Philips highlighted by comparable sales growth and a rebound in new orders. The company is settling litigation related to the global safety recall of its defective respiratory sleep apnea products. Improving financials and declining uncertainties support a positive outlook for the stock.

Philips Q2 Earnings: A Focus On Core Strengths Is The Winning Strategy

Koninklijke Philips N.V. (NYSE:PHG ) Q2 2024 Earnings Conference Call July 29, 2024 4:00 AM ET Company Participants Leandro Mazzoni - Head of Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Richard Felton - Goldman Sachs David Adlington - JPMorgan Veronika Dubajova - Citi Hugo Solvet - Exane BNP Paribas Julien Ouaddour - Bank of America Robert Davies - Morgan Stanley Sezgi Ozener - HSBC Falko Friedrichs - Deutsche Bank Ed Ridley-Day - Redburn Operator Welcome to the Royal Philips Second Quarter and Semiannual 2024 Results Conference Call on Monday, July 29, 2024.

Koninklijke Philips N.V. (PHG) Q2 2024 Earnings Call Transcript

Philips Healthcare beat earnings this morning, reporting $0.52 per share in profit. Sales growth was slow, but Philips promised improvement later in the year.

Why Koninklijke Philips Stock Jumped 14% Today

American depositary receipts (ADRs) of Koninklijke Philips (PHG) jumped Monday after it reporting second-quarter earnings that saw comparable sales increase year-over-year as solid demand in the rest of the world offset a sales drop in China.

Philips Surges as Comparable Sales Grow, Guidance Affirmed

Shares of Philips jumped 8.5% in early deals Monday after the Dutch medical equipment marker reported expectation-beating second-quarter earnings.

Philips shares jump 8% on second-quarter growth in North America

Philips reported second-quarter results that beat analysts' expectations on Monday, boosted by higher earnings and the implementation of its restructuring program.

Philips posts Q2 beat boosted by its restructuring plan

July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2% Comparable order intake increased by 9% Income from operations EUR 816 million, including EUR 538 million insurance income*) Adjusted EBITA margin increased to 11.1% of sales Operating cash inflow of EUR 89 million, with a free cash outflow of EUR 64 million  Roy Jakobs, CEO of Royal Philips: “I am encouraged by our return to order intake growth this quarter, primarily driven by North America. Within a challenging macro environment we achieved strong margin improvement, supported by our productivity program, solid operational cashflow due to improved working capital management and comparable sales growth in line with our plan.

Philips delivers strong order intake growth in the second quarter, margin improvement and sales growth; reiterates full-year outlook

July 17, 2024 Patient monitoring platform to deliver tools and time to help patients across 40+ care sites Amsterdam, the Netherlands, and Cincinnati, Ohio – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation's largest Catholic health systems, today announced a multi-year strategic collaboration for patient monitoring. Putting BSMH clinicians in control, the collaboration will reduce the digital burden on staff and give them more time to spend with patients.

Bon Secours Mercy Health and Philips sign multi-year strategic collaboration

AMSTERDAM & CINCINNATI--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation's largest Catholic health systems, today announced a multi-year strategic collaboration for patient monitoring. Putting BSMH clinicians in control, the collaboration will reduce the digital burden on staff and give them more time to spend with patients. The partnership provides access to the latest Philips monitoring innovation.

Bon Secours Mercy Health and Philips Sign Multi-Year Strategic Collaboration

Philips (PHG) issues an urgent recall of SENSE XL Torso coils (1.5T and 3.0T) due to heating risks during MRI scans.

Philips (PHG) Gains Despite Recall of SENSE XL Torso Coils

Advanced Manufacturing Minneapolis, now open for registration, will discuss and shape the future of the region's manufacturing landscape MINNEAPOLIS, MN / ACCESSWIRE / July 11, 2024 / Advanced Manufacturing Minneapolis , the Midwest's only annual end-to-end design and manufacturing event, today announces its keynote speakers set to discuss topics from artificial intelligence in medical devices to 3D technology in medicine, in the heart of the midwestern hub of medtech innovation, Minneapolis. Advanced Manufacturing Minneapolis, comprised of MD&M (Medical Design & Manufacturing Minneapolis), ATX (Automation Technology Expo), Design & Manufacturing, MinnPack, and Plastec events, returns October 16 &17 after a record-high 2023 event with over 5,300 attendees.

Mayo Clinic and Philips to Keynote at Advanced Manufacturing Minneapolis, Addressing Medical Technological Development

Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "2024 Air Treatment Systems Market: Malaysia" report has been added to ResearchAndMarkets.com's offering.

Malaysia Air Treatment Systems Market Report 2024, Featuring Profiles of Coway, Cuckoo Homesys, Sharp, Koninklijke Philips, Blueair and Amway

U.S. asset management firm Artisan Investments has raised its stake in Philips to 10%, sending the healthcare technology group's shares rising on Wednesday, a week after the Dutch company's biggest shareholder also increased its holding.

Artisan Investments raises stake in Philips to 10%, regulatory filing shows

July 3, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips' Executive Committee, reporting to Philips CEO Roy Jakobs.

Philips appoints Ling Liu as Chief Region Leader of Philips Greater China

Koninklijke Philips N.V. stock was upgraded from sell to hold in April 2023, jumping 28% due to a settlement regarding apnea devices. Despite a €982 million settlement provision for Respironics, adjusted operating income showed improvement in Q1 2024. Philips aims for 3-5% sales growth and 11-11.5% EBITDA margin in 2024, with potential significant upside for 2025.

Philips Stock Surges: Risk Remains On Respironics, But With Investment Potential

Philips shares were up more than 2.5% Wednesday in the wake of a U.S. Securities and Exchange Commission (SEC) filing showing Exor , the investment arm of Italy's Agnelli family, has increased its stake in the Dutch healthcare technology group.

Philips shares up 2.5% after Agnelli family-owned Exor increases stake

June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021.

Philips completes cancellation of 4.4 million shares

Philips (PHG) boosts Diagnosis & Treatment on the back of Precision Diagnosis and Image-Guided Therapy businesses and an expanding partner base.

Philips' (PHG) Diagnosis & Treatment Segment Drives Growth

Morningstar

BARCELONA, Spain--(BUSINESS WIRE)--eDreams ODIGEO (‘The Company'), the world's leading travel subscription platform and one of Europe's largest e-commerce businesses, today announced that it has achieved record customer advocacy and satisfaction levels following the pivot to a subscription-led model. This is supported by millions of data points, including customer related KPIs1 that are included in the Company's Non-financial Statement that is independently verified by external auditors, ensuri.

Subscription Model Drives Record Customer Advocacy and Satisfaction Rates for eDreams ODIGEO

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Future Health Index (FHI) survey conducted by Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, explores the ongoing staffing and access challenges within the US healthcare system and the innovative solutions being used to address them. The ninth annual report, Better care for more people, demonstrates the pressures of staffing shortages and burnout on clinicians and their ability to deliver timely, high-quality care to patients.

88% of US Healthcare Leaders say the use of automation for repetitive tasks is critical for addressing staff shortages in new Philips Future Health Index

June 18, 2024 Healthcare leaders indicate automation is crucial in addressing staff shortages, but staff remain skeptical Interest in Generative AI grows, with majority of health leaders investing in, or planning to invest in AI technologies to help reduce delays in patient care Amsterdam, the Netherlands– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index 2024 report: Better care for more people. Launched at HLTH Europe , the ninth annual FHI global report shows that healthcare leaders are turning to virtual care and AI-enabled innovation to address pressure due to workforce shortages, financial burdens, and growing demand.

Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in patient care

June 17, 2024 Intuitive motorization for greater control and high-power (25 kW [1]) for state-of-the-art image quality supports complex vascular needs and a full range of clinical procedures Automated workflows contribute to greater flexibility and independence for clinicians, providing more time to focus on achieving the best possible outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized , designed to help clinicians deliver high-quality care to more patients. Philips is partnering with its customers to improve productivity.

Philips Zenition 90 Motorized receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm

Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Teeth Whitening Systems Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In an in-depth analysis of the Dental Devices therapeutic area, industry experts have compiled a comprehensive review of the Teeth Whitening Systems market with projections through the year 2033.

Teeth Whitening Systems Market Analysis and Future Outlook Through 2033, Featuring Ultradent Products, Koninklijke Philips, HiSmile and Southern Dental Industries

News for Royal Philips Stock (PHG)